Parekh DJ - Search Results

1

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

Parekh DJ, Punnen S, Sjoberg DD, Asroff SW, Bailen JL, Cochran JS, Concepcion R, David RD, Deck KB, Dumbadze I, Gambla M, Grable MS, Henderson RJ, Karsh L, Krisch EB, Langford TD, Lin DW, McGee SM, Munoz JJ, Pieczonka CM, Rieger-Christ K, Saltzstein DR, Scott JW, Shore ND, Sieber PR, Waldmann TM, Wolk FN, Zappala SM. Parekh DJ, et al. Eur Urol. 2015 Sep;68(3):464-70. doi: 10.1016/j.eururo.2014.10.021. Epub 2014 Oct 27. Eur Urol. 2015. PMID: 25454615

2

Characterization and predictors of prostate specific antigen progression rates after radical retropubic prostatectomy.

Koch MO, Foster RS, Bell B, Beck S, Cheng L, Parekh D, Jung SH. Koch MO, et al. J Urol. 2000 Sep;164(3 Pt 1):749-53. doi: 10.1097/00005392-200009010-00030. J Urol. 2000. PMID: 10953139

3

Pietrow PK, Parekh DJ, Smith JA Jr, Shyr Y, Cookson MS. Pietrow PK, et al. Among authors: parekh dj. J Urol. 2001 Dec;166(6):2286-90. J Urol. 2001. PMID: 11696753

4

Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer.

Clark T, Parekh DJ, Cookson MS, Chang SS, Smith ER Jr, Wells N, Smith J Jr. Clark T, et al. Among authors: parekh dj. J Urol. 2003 Jan;169(1):145-7; discussion 147-8. doi: 10.1016/S0022-5347(05)64055-4. J Urol. 2003. PMID: 12478123 Clinical Trial.

5

Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality.

Parekh DJ, Lin WC, Herrell SD. Parekh DJ, et al. J Urol. 2005 Nov;174(5):1754-8. doi: 10.1097/01.ju.0000177484.33596.c9. J Urol. 2005. PMID: 16217277

6

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.

Parekh DJ, Ankerst DP, Higgins BA, Hernandez J, Canby-Hagino E, Brand T, Troyer DA, Leach RJ, Thompson IM. Parekh DJ, et al. Urology. 2006 Dec;68(6):1152-5. doi: 10.1016/j.urology.2006.10.022. Urology. 2006. PMID: 17169636

7

Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.

Reed A, Ankerst DP, Pollock BH, Thompson IM, Parekh DJ. Reed A, et al. Among authors: parekh dj. J Urol. 2007 Nov;178(5):1929-32; discussion 1932. doi: 10.1016/j.juro.2007.07.045. Epub 2007 Sep 17. J Urol. 2007. PMID: 17868724

8

Assessment of 54 biomarkers for biopsy-detectable prostate cancer.

Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Parekh DJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1966-72. doi: 10.1158/1055-9965.EPI-07-0302. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17932343

9

Biomarkers for prostate cancer detection.

Parekh DJ, Ankerst DP, Troyer D, Srivastava S, Thompson IM. Parekh DJ, et al. J Urol. 2007 Dec;178(6):2252-9. doi: 10.1016/j.juro.2007.08.055. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936845 Review.

10

Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.

Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ. Canby-Hagino E, et al. Among authors: parekh dj. Urology. 2007 Oct;70(4):748-52. doi: 10.1016/j.urology.2007.06.1105. Urology. 2007. PMID: 17991549

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

206 results

Search Page